PODAF - PODAF STOCK NEWS

Poda Lifestyle and Wellness Ltd. announced a landmark clinical study indicating that smokers who switch to tobacco-heating products (THPs) may experience reduced health risks compared to traditional cigarette smoking. Conducted by British American Tobacco, the study highlights significant changes in biomarkers associated with smoking-related diseases. The research, published in the journal Internal and Emergency Medicine, suggests that exclusive use of THPs may lower the risk of several smoking-related illnesses similarly to complete cessation. CEO Ryan Selby believes Poda is well-positioned to capitalize on this shift.

Poda Lifestyle and Wellness Ltd. (CSE: PODA) announced on August 24, 2021, a Consulting Agreement with NKO Consulting Corp. to manage the Premarket Tobacco Product Application (PMTA) process with the US FDA for certain Poda products. The PMTA process, anticipated to take at least 18 months, aims to demonstrate the products' public health benefits. NKO's experience, led by former JUUL labs executive Nick Kadysh, is expected to expedite the process. The agreement aligns with Poda's goal to make its heat-not-burn products available to adult smokers in the USA.

Poda Lifestyle and Wellness Ltd. (CSE: PODA) has entered into a Supply Agreement with Greenbutts, LLC, a biodegradable filter manufacturer. This agreement allows Poda to utilize Greenbutts' fully biodegradable filters for its Beyond Burn™ Poda Pods, which are designed to provide a completely compostable heat-not-burn product. The innovative filters are made from natural materials, decomposing in water within minutes and composting in seven days, addressing environmental concerns linked to traditional cigarette filters. This collaboration bolsters Poda's commitment to strong environmental management and could provide competitive advantages in the market.

Poda Lifestyle and Wellness Ltd. (OTC: PODAF) announced its eligibility for Depository Trust Company (DTC) services, enhancing access for U.S. investors to trade PODAF stock through OTC markets. This move aims to improve liquidity and streamline trading processes. CEO Ryan Selby expressed optimism about expanding the investor base in the U.S. market. Poda is focused on global commercialization of its HNB smoking products, designed to reduce risks associated with combustible smoking. The patented system offers the first ashless HNB cigarettes, combining tea leaves and synthetic nicotine for a smoke-free alternative.

Poda Lifestyle and Wellness Ltd. has announced the initiation of clinical trials for its smoking cessation products, led by Chief Medical Officer Dr. Jagdeep Gupta. These trials aim to establish the efficacy of Poda's products as effective smoking cessation tools and may result in the publication of level 1 evidence in medical journals. Additionally, the company has engaged Command Marketing Inc. to enhance its e-commerce platform and brand identity. Poda's patented HNB system offers a smoke-free alternative for smokers, promoting a healthier lifestyle.

Poda Lifestyle and Wellness Ltd. (CSE: PODA, OTCPINK: PODAF) provided an update on the heated tobacco market, highlighting the rapid growth of reduced-risk products. CEO Ryan Selby noted Philip Morris International's impressive sales of its IQOS product line and its commitment to achieving 50% of revenues from reduced-risk products by 2026. Poda's offerings, designed to eliminate cleaning requirements and potentially lower in price, aim to capitalize on the growing market share of heated tobacco, which is poised to impact 1.3 billion smokers globally.

Poda Lifestyle and Wellness Ltd. announced the appointment of Dr. Jagdeep Gupta as Chief Medical Officer, marking its entry into the medical device market. Dr. Gupta will lead clinical trials for smoking cessation products and oversee the development of inhalable therapeutic molecules. CEO Ryan Selby emphasized the company’s commitment to innovative smoking cessation solutions. Poda’s product aims to utilize precise tapering nicotine doses while addressing oral fixation, enhancing efficacy. Poda is recognized for its patented HNB smoking system that minimizes health risks associated with traditional smoking.

Poda Lifestyle and Wellness Ltd. (OTC PINK: PODAF) announced the appointment of Nicholas Kaydsh, former Head of Corporate Affairs at JUUL Labs Inc., to its Global Advisory Board. With over a decade of experience in public affairs, Kaydsh aims to assist Poda in navigating regulatory challenges as the company expands into the heat-not-burn market. Poda's innovative Beyond Burn™ technology targets 1.3 billion smokers globally. The company granted Kaydsh 435,000 restricted share units at $2.33, which will vest over the next year.

Poda Lifestyle and Wellness Ltd. has announced the appointment of Michael Nederhoff, former President of JUUL Canada, to its Global Advisory Board. This strategic move aims to bolster Poda's global expansion efforts in the heat-not-burn market. Nederhoff's experience includes launching JUUL in Canada and working with significant brands like Red Bull. As part of his contract, Poda granted him 485,000 restricted share units at $1.39. CEO Ryan Selby highlighted the addition of seasoned professionals to support their ambitious growth strategy in the competitive smoking alternatives sector.